Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Cardiotoxicity
- Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
- A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
- Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
- Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity
- Cardiovascular Effects of Intrathecal Hyperbaric Prilocaine or Bupivacaine in Surgery Under Spinal Anesthesia
- Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines
- Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients
- Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
- Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
- Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
- Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines
- Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity
- Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy
- Effect of Trimetazidine on Radiotherapy-induced Heart Damage.
- Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity
- Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
- Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
- Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT
- Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation
- Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
- Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
- Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
- Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
- S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
- Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
- Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study
- STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
- Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
- Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
- Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity
- STOP Heart Disease in Breast Cancer Survivors Trial
- Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
- Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab
- Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification
- Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
- Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
- Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients
- Spironolactone Against Anthracycline-induced Cardiomyopathy
- Prevention of Anthracycline-induced Cardiotoxicity
- Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity
- Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination
- Early Cardiac Toxicity of Adjuvant CT in Elderly BC.
- Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer
- Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
- Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
- Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
- Cardiac Magnetic Resonance Imaging in Patients With Newly Diagnosed Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
- Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma
- Staccato Prochlorperazine Thorough QT/QTc
- The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity
- Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
- Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
- Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients
- Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
- Prevention of CHOP-induced Chronic Cardiotoxicity
- Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors
- Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
- Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
- Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
- Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
- Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
- Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease